A letter from America to Dr. Endo

Atherosclerosis Supplements

Volumn 5, Issue 3 SPEC.ISS., 2004, Pages 17-18

  Grundy, Scott M ^a,b  

^a The Intl Atherosclerosis Society   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; COLESTYRAMINE; COMPACTIN; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NICOTINIC ACID;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; HEART DISEASE; HUMAN; LETTER; LIPOPROTEIN METABOLISM; METABOLIC SYNDROME X; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; RISK REDUCTION; SAFETY; X RAY;

EID: 8644241630     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosissup.2004.08.008     Document Type: Article

References (3)

1. D.W. Bilheimer, S.M. Grundy, M.S. Brown, and J.L. Goldstein Mevinolin and colestipol stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes Proc Natl Acad Sci USA 80 1983 4124 4128
2. A. Garg, and S.M. Grundy Lovastatin for lowering cholesterol levels in noninsulin-dependent diabetes mellitus N Engl J Med 313 1988 81 86
3. C. East, S.M. Grundy, and D.W. Bilheimer Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation JAMA 256 1986 2843 2848